Results 141 to 150 of about 1,909 (168)

An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment. [PDF]

Mol Ther Nucleic Acids
Maeda K, Hirunagi T, Sahashi K, Kamiya Y, Iida M, Sakakibara K, Onodera K, Ohyama M, Okada Y, Okano H, Asanuma H, Katsuno M.   +11 more
europepmc   +1 more source

Smart Nanoparticles Disrupting Energy Supply through Triple Mechanisms to Kill Tumors via Dual Disruption of Mitochondria and Lysosomes. [PDF]

Adv Sci (Weinh)
Xu X, Huang Q, Liu Y, Liu J, Yang D, Song Y, Han X.   +6 more
europepmc   +1 more source

Tailored antisense oligonucleotides for ultrarare CNS diseases: An experience-based best practice framework for individual patient evaluation. [PDF]

Mol Ther Nucleic Acids
Schüle R, Graessner H, Aartsma-Rus A, van Roon-Mom WMC, N=1 Collaborative (N1C), 1 Mutation 1 Medicine Consortium (1M1M), Synofzik M.   +6 more
europepmc   +1 more source

Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSV. [PDF]

Mol Ther Nucleic Acids
Maziec K, Baliga-Gil A, Kierzek E.
europepmc   +1 more source

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly